Hikma Pharmaceuticals dans l'actualité
Médicaments accessibles de haute qualité
Tamtam a trouvé 13 articles récents sur Hikma Pharmaceuticals.
- Hikma stock heads into the open after a modest gain
- What Does Hikma Pharmaceuticals' (LSE:HIK) Dividend Mean For UK Holders?
- Hikma Pharmaceuticals climbs Friday, outperforms market
- A needle-free epinephrine spray is under review in the US, Europe and UK
- Hikma advances its epinephrine nasal spray with multi-market regulatory filings
- Hikma Pharmaceuticals (LSE:HIK) Stock Fair Value Edges Higher After Bullish Analyst Targets
- ii view: Hikma keeps a healthy pulse with solid first half
- Hikma Pharmaceuticals rallies on improving trends
- Hikma Pharmaceuticals Number of Employees 2026 | Employee Count & Headcount Data
- Rep. Cockley Applauds Hikma Pharmaceuticals Expansion, Investment in Columbus Workforce | Republican News
- Skinny labelling after Hikma v Amarin: active inducement in the US Supreme Court (via Passle)
- Hikma Pharmaceuticals Announces Major Expansion in Ohio, Creating 350 New Jobs and Investing $267 Million
- Justices poised to protect generics manufacturers from liability for decisions of pharmacists about prescribing their products
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme Hikma Pharmaceuticals ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires